HomeComparePKPH vs PLD

PKPH vs PLD: Dividend Comparison 2026

PKPH yields 129.03% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKPH wins by $6.04M in total portfolio value
10 years
PKPH
PKPH
● Live price
129.03%
Share price
$1.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11.95M
Annual income
$4,733,958.72
Full PKPH calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — PKPH vs PLD

📍 PKPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKPHPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKPH + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKPH pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKPH
Annual income on $10K today (after 15% tax)
$10,967.74/yr
After 10yr DRIP, annual income (after tax)
$4,023,864.91/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $14,251.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKPH + PLD for your $10,000?

PKPH: 50%PLD: 50%
100% PLD50/50100% PKPH
Portfolio after 10yr
$8.93M
Annual income
$4,742,341.95/yr
Blended yield
53.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

PKPH
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKPH buys
0
PLD buys
0
No recent congressional trades found for PKPH or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKPHPLD
Forward yield129.03%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$11.95M$5.91M
Annual income after 10y$4,733,958.72$4,750,725.19
Total dividends collected$10.93M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PKPH vs PLD ($10,000, DRIP)

YearPKPH PortfolioPKPH Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$23,603$12,903.23$11,241$540.96+$12.4KPKPH
2$53,719$28,463.34$13,019$991.13+$40.7KPKPH
3$118,021$60,542.03$15,801$1,870.97+$102.2KPKPH
4$250,593$124,310.20$20,609$3,701.21+$230.0KPKPH
5$514,813$246,678.79$29,919$7,867.97+$484.9KPKPH
6$1,024,469$473,618.88$50,631$18,617.74+$973.8KPKPH
7$1,977,016$880,834.70$105,528$51,352.20+$1.87MPKPH
8$3,704,035$1,588,627.70$287,364$174,449.42+$3.42MPKPH
9$6,744,972$2,781,654.52$1,081,760$774,280.77+$5.66MPKPH
10$11,951,079$4,733,958.72$5,908,209$4,750,725.19+$6.04MPKPH

PKPH vs PLD: Complete Analysis 2026

PKPHStock

Peak Pharmaceuticals, Inc. operates as a bio­pharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THC­free, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.

Full PKPH Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this PKPH vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKPH vs SCHDPKPH vs JEPIPKPH vs OPKPH vs KOPKPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.